LGG after biopsy or partial resection at a previous surgery, who progressed with increasing seizures and/or radiologically, received 1 week on/1 week off temozolomide to a maximum of 12 cycles. Response on MRI-FLAIR images was evaluated every 3 months based on RANO and volumetric criteria. Changes on diffusion tensor imaging (DTI) were assessed by histogram analysis and Functional Diffusion Maps and compared with RANO and volumetric criteria, and response of seizures. RESULTS: 24 patients with an histological diagnosis of LGG according to WHO 2007 were enrolled from 2008 to 2013: 19/ 24 males, median age 32 years (range 23-56) and median KPS 90. Reasons for
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